The 3-phenylcoumarin derivative 6,7-dihydroxy-3-[3 ',4 '-methylenedioxyphenyl]-coumarin downmodulates the Fc gamma R- and CR-mediated oxidative metabolism and elastase release in human neutrophils: Possible mechanisms underlying inhibition of the formation and release of neutrophil extracellular traps

Autor(es):Mostrar menos -

Andrade, Micassio F. ; Kabeya, Luciana M. ; Bortot, Leandro O. ; dos Santos, Gabriela B. ; Santos, Everton O. L. ; Albiero, Lucineia R. ; Figueiredo-Rinhel, Andrea S. G. ; Carvalho, Camila A. ; Azzolini, Ana Elisa C. S. ; Caliri, Antonio ; Pupo, Monica T. ; Emery, Flavio S. ; Lucisano-Valim, Yara Maria

• Tipo de documento: Artigo Científico
• Fonte: Free Radical Biology and Medicine; v. 115, p. 15-pg., 2018-02-01.

Resumo

In this study, we report the ability of a set of eight 3-phenylcoumarin derivatives bearing 6,7- or 5,7-dihydroxyl groups, free or acetylated, bound to the benzopyrone moiety, to modulate the effector functions of human neutrophils. In general, (i) 6,7-disubstituted compounds (5, 6, 19, 20) downmodulated the Fc gamma receptor-mediated neutrophil oxidative metabolism more strongly than 5,7-disubstituted compounds (21, 22, 23, 24), and (ii) hydroxylated compounds (5, 19, 21, 23) downmodulated this neutrophil function more effectively than their acetylated counterparts (6, 20, 22, 24, respectively). Compounds 5 (6,7-dihydroxy-3-[3',4'-methylenedioxyphenyl]-coumarin) and 19 (6,7-dihydroxy-3-[ 3', 4'-dihydroxyphenyl]-coumarin) effectively downmodulated the neutrophil oxidative metabolism elicited via Fc gamma and/or complement receptors. Compound 5 also downmodulated the immune complex-stimulated phagocytosis, degranulation of elastase, and production and release of neutrophil extracellular traps, as well as the human neutrophil chemotaxis towards n-formyl-methionylleucyl-phenylalanine, without altering the expression level of formyl peptide receptor type 1. Both compounds 5 and 19 did not impair the neutrophil capacity to recognize and kill Candida albicans. Docking calculations revealed that compounds 5 and 19 directly interacted with three catalytic residues - Gln-91, His-95, and Arg-239 - inside the myeloperoxidase active site. Together, these findings indicate that (i) inhibition of reactive oxygen species generation and degranulation of elastase are closely associated with downmodulation of release of neutrophil extracellular traps; and (ii) compound 5 can be a prototype for the development of novel immunomodulating drugs to treat immune complex-mediated inflammatory diseases. (AU)

• Processo FAPESP: 10/19504-0 - Estudo do mecanismo da atividade antioxidante de Baccharis dracunculifolia (Asteraceae) em neutrófilos e avaliação deste efeito sobre modelo de artrite reumatóide
• Beneficiário: Andréa Silva Garcia de Figueiredo Rinhel
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 12/23541-4 - Avaliação in vitro dos efeitos antioxidante e anti-inflamatório de derivados 3-fenilcumarínicos em neutrófilos humanos estimulados e em modelo animal de artrite
• Beneficiário: Micássio Fernandes de Andrade
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 13/20810-7 - Estudo sistemático dos mecanismos moleculares envolvidos na inibição do metabolismo oxidativo de neutrófilos exercida pela Baccharis dracunculifolia, derivado 3-fenilcumarinicos e 3,5,7-triidroxiflavona: implicação em uma nova abordagem terapêutica da AR
• Beneficiário: Yara Maria Lucisano Valim
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 13/00927-7 - Simulações de dinâmica molecular na identificação de moléculas bioativas: inibidores da interação entre a glicoproteína do envelope do vírus da dengue e lectinas tipo-C celulares
• Beneficiário: Leandro Oliveira Bortot
• Modalidade de apoio: Bolsas no Brasil - Doutorado Direto
• Processo FAPESP: 98/14107-0 - Planejamento racional de drogas antichagasicas: sintese de cumarinas inibidoras da enzima gliceraldeido-3-fosfato desidrogenase (gapdh) de trypanosoma cruzi.
• Beneficiário: Mônica Tallarico Pupo
• Modalidade de apoio: Auxílio à Pesquisa - Regular